Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Angelo Marzano"'
Autor:
Martina Merli, Martina Accorinti, Maurizio Romagnuolo, Angelo Marzano, Giovanni Di Zenzo, Francesco Moro, Emiliano Antiga, Roberto Maglie, Emanuele Cozzani, Aurora Parodi, Giulia Gasparini, Pietro Sollena, Clara De Simone, Marzia Caproni, Luigi Pisano, Davide Fattore, Riccardo Balestri, Paolo Sena, Pamela Vezzoli, Miriam Teoli, Marco Ardigò, Camilla Vassallo, Andrea Michelerio, Rosanna Rita Satta, Emi Dika, Barbara Melotti, Simone Ribero, Pietro Quaglino
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
Cutaneous immune-related adverse events are frequently associated with immune checkpoint inhibitors (ICIs) administration in cancer patients. In fact, these monoclonal antibodies bind the cytotoxic T-lymphocyte antigen-4 and programmed cell death-1/l
Externí odkaz:
https://doaj.org/article/54cab3571bda4d5c925013a4dc3c5c86
Autor:
Giulia Murgia, Nerina Denaro, Francesca Boggio, Gianluca Nazzaro, Valentina Benzecry, Paolo Bortoluzzi, Emanuela Passoni, Ornella Garrone, Angelo Marzano
Publikováno v:
Cells, Vol 12, Iss 23, p 2737 (2023)
Basosquamous carcinoma (BSC), an uncommon and aggressive nonmelanoma skin cancer exhibiting characteristics ranging from basal cell carcinoma (BCC) to squamous cell carcinoma (SCC), is a subject of controversy in terms of its classification, pathogen
Externí odkaz:
https://doaj.org/article/4436753bc16a48078b356444b8fa1969
Autor:
Angelo Marzano
Publikováno v:
Revista de Educação Física, Vol 41, Iss 1 (2020)
...
Externí odkaz:
https://doaj.org/article/0038601f6a064a6cbcd72e3113596fbc
Autor:
Stephane Jamain, Michele Boniotto, Sergio Crovella, Damiano Abeni, Luca Fania, Angelo Marzano, Chiara Moltrasio, D’Adamo Pio, Paola Tricarico, Ana Sofia Lima Estevao de Oliveira
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05d44ff0003f1f4576ebca5f1e5ba2b5
https://doi.org/10.26226/m.62fa009b10629d001aa58d95
https://doi.org/10.26226/m.62fa009b10629d001aa58d95
Publikováno v:
Journal of drugs in dermatology : JDD. 21(8)
The efficacy of guselkumab has been demonstrated in randomized controlled trials, but real-life data are still missing. This study presents a single-center real-life experience in treating moderate-to-severe plaque psoriasis with guselkumab, underlyi
Autor:
David, Baltazar, Carter, Haag, Angela S, Gupta, Angelo Marzano, Marzano, Alex G, Ortega Loayza
Publikováno v:
Wounds : a compendium of clinical research and practice. 31(6)
Pyoderma gangrenosum (PG) is a rare, ulcerative inflammatory skin disease that most commonly occurs in patients with inflammatory bowel disease, rheumatologic diseases, or hematologic diseases. Successful treatment of PG often requires immunosuppress
Autor:
Baltazar D; College of Osteopathic Medicine of the Pacific-Northwest, Western University of Health Sciences, Pomona, CA., Haag C; Oregon Health and Science University, Portland, OR., Gupta AS; Virginia Commonwealth School of Medicine, Richmond, VA., Marzano AM; U.O.C. Dermatologia - Dipartimento di Fisopatologia Medico-Chirurgica e dei Trapianti, Università degli Studi di Milano - Fondazione IRCCS Ca' Granda Ospedale Maggiore Pliclinico, Milano, Italy., Ortega Loayza AG; Department of Dermatology, Oregon Health and Science University, Portland, OR.
Publikováno v:
Wounds : a compendium of clinical research and practice [Wounds] 2019 Jun; Vol. 31 (6), pp. 151-157.